Mounia Chaoui-Roulleau

Director/Board Member at

Institut National de la Santé & de la Recherche Médicale

54 year

70 connections

Health Technology

Finance

Commercial Services

Profile

Mounia Chaoui-Roulleau currently works at Institut National de la Santé & de la Recherche Médicale, as Director, Eye Tech Care SA, as Director from 2014, PhysioAssist SAS, as Director, Turenne Capital Partenaires SA, as Partner from 2013, Intrexon ActoBiotics NV, as Member-Supervisory Board from 2014, and Themis Bioscience GmbH, as Member-Supervisory Board.
Dr. Chaoui-Roulleau also formerly worked at Finbiomed SARL, as Chief Executive Officer from 2013 to 2020, BioVex, Inc., as Director from 2009 to 2011, Xytis, Inc., as Director, TiGenix NV, as Non-Executive Director, Kiora Pharmaceuticals, Inc., as Director from 2013 to 2016, SCYNEXIS, Inc., as Independent Director in 2014, Aptanomics SA, as Director, Prosonix Ltd., as Non-Executive Director, TiGenix SAU, as Director from 2007 to 2012, Funxional Therapeutics Ltd., as Director from 2011 to 2012, DNA Therapeutics SASU, as Director, Amolyt Pharma SAS, as Director, Millendo Therapeutics SAS, as Director, Altran Technologies SA, as Principal from 1999 to 2001, Sofimac Innovation SAS, as Managing partner from 2012 to 2020, Telesis, as Principal in 1999, Ventech SA, as General Partner from 2011 to 2013, INSERM Transfert SA, as Managing Partner in 2012, and Covagen AG, as Member-Supervisory Board.
Dr. Chaoui-Roulleau received her undergraduate degree in 1995 from École Centrale Paris and doctorate degree from Université Pierre et Marie Curie.

Mounia Chaoui-Roulleau active positions

Companies	Position	Start
Institut National de la Santé & de la Recherche Médicale Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Research institute	Director/Board Member	25/11/2009
Intrexon ActoBiotics NV Intrexon ActoBiotics NV BiotechnologyHealth Technology Manufactures biopharmaceutical products	Director/Board Member	-
Eye Tech Care SA Eye Tech Care SA Medical SpecialtiesHealth Technology Develops medical devices for non-invasive eye disease treatment	Director/Board Member	01/07/2014
Physio-Assist SAS Physio-Assist SAS Medical SpecialtiesHealth Technology Develops and manufactures medical equipment	Director/Board Member	-
Turenne Capital Partenaires SA Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital invests in small and middle market companies located in France. The firm focuses on healthcare, hospitality, environment, energetic transition and innovacom sectors. It participates in seed, early and later stage transactions with an investment size of less than EUR 30 million.	Private Equity Investor	01/05/2013

All active positions of Mounia Chaoui-Roulleau

Former positions of Mounia Chaoui-Roulleau

Companies	Position	End
Themis Bioscience GmbH Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops vaccines to prevent infectious diseases	Director/Board Member	27/07/2022
Sofimac Innovation SAS Sofimac Innovation SAS Investment ManagersFinance Sofimac Innovation is an active manager which prefers to invest equity to create or grow limited liability companies in the ICT sector. The firm invests principally in France and Western European countries because they believe that geographical proximity between investee companies and their team is necessary to provide effective support. Sofimac Innovation typically invests €0.5-€1.5 million in the first round in early-stage companies and €0.5-€3 million with co-investors in subsequent rounds when necessary. The firm works in partnership with their investee companies, providing expertise to support them in assessing and positioning their new technology in their competitive environment, measuring and developing the managing team's potential for success and building the foundations that will allow the company to transform the initial concept into reality. Sofimac Innovation aims to invest in companies which have a technological innovation with growth potential, a quality management team, technological intensity and barriers to entry (including intellectual property rights ownership), a large target market with significant growth potential, a robust marketing strategy and a project in its final stage of development.	Private Equity Investor	31/12/2020
Finbiomed SARL	Chief Executive Officer	31/12/2020
KIORA PHARMACEUTICALS, INC.	Director/Board Member	22/06/2016
░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░

See the detail of Mounia Chaoui-Roulleau's experience

Training of Mounia Chaoui-Roulleau

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mounia Chaoui-Roulleau's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	27
Altran Technologies SA Altran Technologies SA Packaged SoftwareTechnology Services Develops software, digital tools and technology for the physical engineering & product development sectors	Technology Services
BioVex, Inc. BioVex, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases	Health Technology
Xytis, Inc. Xytis, Inc. BiotechnologyHealth Technology Develops & discovers CNS drug candidates	Health Technology
TiGenix NV TiGenix NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapeutic	Health Technology
Kiora Pharmaceuticals, Inc. Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases	Health Technology
Sofimac Innovation SAS Sofimac Innovation SAS Investment ManagersFinance Sofimac Innovation is an active manager which prefers to invest equity to create or grow limited liability companies in the ICT sector. The firm invests principally in France and Western European countries because they believe that geographical proximity between investee companies and their team is necessary to provide effective support. Sofimac Innovation typically invests €0.5-€1.5 million in the first round in early-stage companies and €0.5-€3 million with co-investors in subsequent rounds when necessary. The firm works in partnership with their investee companies, providing expertise to support them in assessing and positioning their new technology in their competitive environment, measuring and developing the managing team's potential for success and building the foundations that will allow the company to transform the initial concept into reality. Sofimac Innovation aims to invest in companies which have a technological innovation with growth potential, a quality management team, technological intensity and barriers to entry (including intellectual property rights ownership), a large target market with significant growth potential, a robust marketing strategy and a project in its final stage of development.	Finance
Telesis Telesis Miscellaneous Commercial ServicesCommercial Services Provides management consulting services	Commercial Services
Turenne Capital Partenaires SA Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital invests in small and middle market companies located in France. The firm focuses on healthcare, hospitality, environment, energetic transition and innovacom sectors. It participates in seed, early and later stage transactions with an investment size of less than EUR 30 million.	Finance
Ventech SA Ventech SA Investment ManagersFinance Ventech invests in companies located in Europe, primarily in France, Germany, the DACH region, the Nordics region and the United States. The firm focuses on a broad range of sectors and industries. It participates in pre-seed, seed and early stage capital requirements with an investment size of EUR 0.15 - 5 million.	Finance
SCYNEXIS, Inc. SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections	Health Technology
Aptanomics SA Aptanomics SA Pharmaceuticals: MajorHealth Technology Develops and manufactures novel therapeutics	Health Technology
INSERM Transfert SA INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions.	Finance
Institut National de la Santé & de la Recherche Médicale Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Research institute	Commercial Services
École Centrale Paris École Centrale Paris Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Université Pierre et Marie Curie Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Intrexon ActoBiotics NV Intrexon ActoBiotics NV BiotechnologyHealth Technology Manufactures biopharmaceutical products	Health Technology
Prosonix Ltd. Prosonix Ltd. Pharmaceuticals: MajorHealth Technology Develops a portfolio of inhaled respiratory medicines	Health Technology
Cellerix SA Cellerix SA Pharmaceuticals: GenericHealth Technology Develops and manufactures pharmaceutical products	Health Technology
Funxional Therapeutics Ltd. Funxional Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides drug and therapeutical development services	Health Technology
DNA Therapeutics SASU DNA Therapeutics SASU BiotechnologyHealth Technology Engages in the development of drugs for cancer treatment	Health Technology
Eye Tech Care SA Eye Tech Care SA Medical SpecialtiesHealth Technology Develops medical devices for non-invasive eye disease treatment	Health Technology
Covagen AG Covagen AG BiotechnologyHealth Technology Develops next generation protein drugs for the treatment of inflammatory diseases and cancer	Health Technology
Millendo Therapeutics SAS Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Provides pharmaceutical research services	Health Technology
Themis Bioscience GmbH Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops vaccines to prevent infectious diseases	Health Technology
Finbiomed SARL
Amolyt Pharma SAS Amolyt Pharma SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical & natural sciences	Commercial Services
Physio-Assist SAS Physio-Assist SAS Medical SpecialtiesHealth Technology Develops and manufactures medical equipment	Health Technology